Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Hepatitis C virus seroconversion in a hemophiliac treated exclusively with solvent/detergent-treated clotting factor concentrate

Abstract

Tremendous efforts have been made to prevent the transmission of infectious agents by clotting factor concentrates. Blood donors are carefully selected, each blood donation is tested for common blood-transmissible viruses, and then the clotting factor concentrates are virus inactivated.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, Holmes EC: Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. Journal of General Virology 1994, 75: 1053–1061.

  2. 2.

    Rollag H, Evensen SA, Frøland SS, Glomstein A: Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools. European Journal of Clinical Microbiology & Infectious Diseases 1990: 9: 612–614.

  3. 3.

    Suzuki K, Mizokami M, Lau JYN, Mizoguchi M, Kato K, Mizuno Y, Sodeyama T, Kiyosawa K, Gojobori T: Confirmation of hepatitis C virus through needlestick accidents by molecular evolutionary analysis. Journal of Infectious Diseases 1994, 170: 1575–1578.

  4. 4.

    Allander T, Gruber A, Naghavi M, Beyene A, Söderström T, Björkholm M, Grillner L, Persson MAA: Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995, 345: 603–607.

  5. 5.

    Aricò M, Maggiore G, Silini E, Bono F, Viganò C, Cerino A, Mondelli MU: Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994, 84: 2919–2922.

  6. 6.

    Napoli N, Fiore G, Vella F, Fera G, Schiralsi O: Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C. European Journal of Epidemiology 1993, 9: 629–632.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Evensen, S.A., Rollag, H. & Glomstein, A. Hepatitis C virus seroconversion in a hemophiliac treated exclusively with solvent/detergent-treated clotting factor concentrate. Eur. J. Clin. Microbiol. Infect. Dis. 14, 631–632 (1995). https://doi.org/10.1007/BF01690743

Download citation

Keywords

  • Hepatitis
  • Internal Medicine
  • Blood Donation
  • Infectious Agent
  • Clotting Factor